期刊文献+

ST-elevation myocardial infarction caused by very late stent thrombosis due to drug-eluting stent fracture

ST-elevation myocardial infarction caused by very late stent thrombosis due to drug-eluting stent fracture
原文传递
导出
摘要 Although the incidence of coronary stent fracture (SF) is relatively rare, the increasing amount of patients v undergoing percutaneous indicates more cases coronary- intervention (PCI) of SF. The incidence of sirolimus-eluting stent (SES) fracture is reported in 0.89% to 4.4% of patients at 6 to 12 months follow-up 12 anglography post-PCI. Recently, SF has been recognized as a complication that may result in thrombosis, perforation, restenosis, and migration of the stent resulting in morbidity and mortality. Here we describe a rare case presented with ST-elevation myocardial infarction (STEMI), which was caused by very late stent thrombosis due to SES fracture, in order to help the physicians ensure rapid recognition and treatment of this urgent situation. Although the incidence of coronary stent fracture (SF) is relatively rare, the increasing amount of patients v undergoing percutaneous indicates more cases coronary- intervention (PCI) of SF. The incidence of sirolimus-eluting stent (SES) fracture is reported in 0.89% to 4.4% of patients at 6 to 12 months follow-up 12 anglography post-PCI. Recently, SF has been recognized as a complication that may result in thrombosis, perforation, restenosis, and migration of the stent resulting in morbidity and mortality. Here we describe a rare case presented with ST-elevation myocardial infarction (STEMI), which was caused by very late stent thrombosis due to SES fracture, in order to help the physicians ensure rapid recognition and treatment of this urgent situation.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第15期2794-2796,共3页 中华医学杂志(英文版)
关键词 myocardial infarction drug-eluting stents fracture coronary angioplasty myocardial infarction drug-eluting stents, fracture coronary angioplasty
  • 相关文献

参考文献5

  • 1Park KW, Park J J, Chae IH, Seo JB, Yang HM, Lee HY, et al. Clinical characteristics of coronary drug-eluting stent fracture: insights from a two-center DES registry. J Korean Med Sci 2011; 26: 53-58.
  • 2Popma JJ, Tiroch K, Almonacid A, Cohen S, Kandzari DE, Leon MB. A qualitative and quantitative angiographic analysis of stent fracture late following sirolimus-eluting stent implantation. Am J Cardio12009; 103: 923-929.
  • 3Lee MS, Jurewitz D, Aragon J, Forrester J, Makkar RR, Kar S. Stent fracture associated with drug-eluting stents: clinical characteristics and implications. Catheter Cardiovasc Interv 2007; 69: 387-394.
  • 4Ino Y, Toyoda Y, Tanaka A, Ishii S, Kusuyama Y, Kubo T, et al. Predictors and prognosis of stent fracture after sirolimus- eluting stent implantation. Circ J 2009; 73: 2036-2041.
  • 5Kim U, Kim DI, Kim DK, Seol SH, Jang JS, Yang TH, et al. Long-term clinical and angiographic outcomes of patients with sirolimus-eluting stent fracture. Int J Cardiol 2011; Epub ahead of print.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部